Ceruvia Lifesciences
Ceruvia Lifesciences is a developer of neuro transformational medicines for neurological diseases.
Ceruvia Lifesciences is a developer of neuro transformational medicines for neurological diseases.
Ceruvia Lifesciences has raised $8.0M across 1 round. Its most recent round was a Series Unknown of $8.0M in Aug 2026. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles, verified email addresses and LinkedIn profiles.
Ceruvia Lifesciences is featured in
Similar companies
ScopeSys is a commercial-stage developer of disruptive technologies for single-molecule imaging.
PointsKash is a mobile application that converts users' reward points into cash on every transaction.
Databricks is a data and AI platform that unifies data engineering, analytics, and machine learning on a lakehouse architecture.
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both autoimmunity and cancer. They leverage the systematic target validation and clinical insights gained by its founders to identify new targets. Their intensive use of bioinformatics to interrogate the transcriptome of human disease together with ex-vivo validation in diseased tissue has uncovered new approaches to target key compartments of the immune system. The company was incorporated in 2015 and is based in Newton, Massachusetts.
Petfolk is a veterinary healthcare organization that offers an integrated platform for veterinarians, pets, and pet owners to connect. Their unique approach incorporates telehealth services alongside physical clinics and mobile units, streamlining the process of booking appointments and receiving follow-up care instructions. Established in 2020, Petfolk was created by highly experienced veterinarians based in Charlotte, North Carolina.
First Bite is a go-to-market software platform for food manufacturers.
Khartis Therapeutics is a biotech company developing oral small-molecule medicines for immune-mediated and chronic diseases.
Terram Lab is to eliminate plastic and harmful chemicals from packaging.
Revolutionary Aligner Technology using AI for more predictable and more reliable outcomes helping millions of dentist and patients globally
3852.ai uses predictive artificial intelligence to develop a combination treatments for difficult-to-treat illnesses.
Bula provides a mobile wallet and platform for organizing, staking, and settling peer-to-peer skill-based golf bets and matches.
Riven uses AI and autonomous labs to optimize mineral processing.
Know who just raised. Then know who to call.
Every newly funded startup with its round, its investors, and its founders — delivered weekly, or searchable back to 2020.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.